Entries tagged "Valeant Pharmaceuticals International Inc."

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Valeant Pharmaceuticals International Inc.."

10 result(s) displayed (1 - 10 of 10)

Actavis acquires Warner Chilcott for $8.5B

Deal represents a 34% premium to Dublin target's share price prior to May 9 disclosure of merger discussions. Continue reading

Posted on May 20, 2013 9:28 AM

Valeant puts more skin in game with Obagi deal

The acquisitive drugmaker will pay $19.75 per share in cash for the Long Beach, Calif.-based dermatology products company, an offer representing a 28% premium to the target's stock price. Continue reading

Posted on March 20, 2013 12:41 PM

Endo hires Valeant dealmaker as new CEO

Rajiv De Silva comes to the healthcare conglomerate to lead an operational turnaround after helping make and integrate 40 acquisitions at his former employer. Continue reading

Posted on February 27, 2013 12:35 PM

Valeant to pay $2.6B for Medicis

The deal caps a long series of smaller acquisitions by the Canadian pharmaceutical company, which lost out in the bidding for Cephalon in May last year Continue reading

Posted on September 4, 2012 11:39 AM

Water Street quickly raises $750M for new buyout pool

The healthcare-focused private equity firm spends just eight weeks gathering commitments Continue reading

Posted on July 31, 2012 2:42 PM

Valeant blinks and withdraws Ista bid

The Canadian pharmaceutical company pulls its unsolicited bid for the ophthalmic drugmaker Continue reading

Posted on January 30, 2012 12:04 PM

ISTA rejects unsolicited Valeant bid

The takeover target argues that the $327 million offer is inadequate. Continue reading

Posted on December 16, 2011 1:22 PM

Valeant steps into Afexa's hostile situation

Rather than let shareholders ruminate on a hostile bid from Paladin Labs Inc., Afexa Life Sciences Inc. has found a better offer on its own.Afexa announced on Tuesday, Aug. 30, that it has signed a deal to be acquired by... Continue reading

Posted on August 30, 2011 2:37 PM

The new brand of generic

Teva gets Cephalon and becomes a drug company of a different sort. Continue reading

Posted on May 6, 2011 12:45 PM

Deal diary: April 11-24, 2011

Valeant taps S&C for its hostile bid, Shearman nudges aside Skadden at Nasdaq, Advantest conquers tremors for Verigy, Latham says goodbye to National Semi, and Dewey keeps doing it for eBay. Continue reading

Posted on April 8, 2011 11:40 AM

Movable Type search results powered by Fast Search